Literature DB >> 9267316

Serum concentrations of myoglobin vs human heart-type cytoplasmic fatty acid-binding protein in early detection of acute myocardial infarction.

J Ishii1, J H Wang, H Naruse, S Taga, M Kinoshita, H Kurokawa, M Iwase, T Kondo, M Nomura, Y Nagamura, Y Watanabe, H Hishida, T Tanaka, K Kawamura.   

Abstract

We compared the diagnostic utility of serum concentrations of human heart-type cytoplasmic fatty acid-binding protein (H-FABPc), myoglobin, and their ratio for the early diagnosis of acute myocardial infarction (AMI) in 104 healthy volunteers and 165 patients at admission within 6 h of the onset of chest pain. The ROC curves of the H-FABPc [0.946, 95% confidence interval (CI) = 0.913-0.979] and myoglobin (0.895, 95% CI = 0.846-0.944) between patients with AMI and healthy volunteers were significantly greater than the area under the ratio of myoglobin to H-FABPc (0.823, 95% CI = 0.765-0.881). In 165 patients, the sensitivity (81.8%, 95% CI = 74.2-89.4%), specificity (86.4%, 95% CI = 78.1-94.6%), and predictive accuracy (83.6%, 95% CI = 78.0-89.3%) of H-FABPc > 12 micrograms/L in diagnosing AMI were significantly higher than those of myoglobin, and were similar to those of the combination of H-FABPc > 12 micrograms/L and the ratio < or = 14. We conclude that H-FABPc is a more sensitive and specific marker than myoglobin for the early diagnosis of AMI, and that their ratio cannot give a clear advantage over the measurement of H-FABPc alone.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9267316

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  24 in total

1.  Heart-type, fatty-acid binding protein can be a diagnostic marker in acute coronary syndromes.

Authors:  Umut Cavus; Figen Coskun; Bunyamin Yavuz; Orcun Ciftci; Levent Sahiner; Hakan Aksoy; Ali Deniz; Engin Ozakin; Kudret Aytemir; Lale Tokgozoglu; Giray Kabakci
Journal:  J Natl Med Assoc       Date:  2006-07       Impact factor: 1.798

2.  Sorting through new biomarkers.

Authors:  Frances O Wood; James A de Lemos
Journal:  Curr Cardiol Rep       Date:  2008-07       Impact factor: 2.931

3.  Comparative study of high sensitivity troponin T and heart-type fatty acid-binding protein in STEMI patients.

Authors:  Shaheena Banu; Syed Tanveer; C N Manjunath
Journal:  Saudi J Biol Sci       Date:  2014-06-10       Impact factor: 4.219

4.  An evidence-based approach to the assessment of heart-type Fatty Acid binding protein in acute coronary syndrome.

Authors:  Karthik Viswanathan; Alistair S Hall; Julian H Barth
Journal:  Clin Biochem Rev       Date:  2012-02

5.  The role of heart-type fatty acid-binding protein in the diagnosis of acute coronary syndrome.

Authors:  Jonathan Rosman; Gita Kavala; Kotoro Obunai; Steven R Bergmann
Journal:  Int J Angiol       Date:  2009

6.  Highly sensitive single polyaniline nanowire biosensor for the detection of immunoglobulin G and myoglobin.

Authors:  Innam Lee; Xiliang Luo; Xinyan Tracy Cui; Minhee Yun
Journal:  Biosens Bioelectron       Date:  2011-01-06       Impact factor: 10.618

7.  Utility of Heart-type Fatty Acid Binding Protein as a New Biochemical Marker for the Early Diagnosis of Acute Coronary Syndrome.

Authors:  Bhakti N Gami; Dharmik S Patel; N Haridas; Kiran P Chauhan; Hitesh Shah; Amit Trivedi
Journal:  J Clin Diagn Res       Date:  2015-01-01

8.  Evaluation of the diagnostic performance of heart-type fatty acid binding protein in the BWH-TIMI ED chest pain study.

Authors:  Christian T Ruff; Marc P Bonaca; Joshua M Kosowsky; Michael J Conrad; Sabina A Murphy; Petr Jarolim; Sean M Donahoe; Michelle L O'Donoghue; David A Morrow
Journal:  J Thromb Thrombolysis       Date:  2013-11       Impact factor: 2.300

9.  Increased H-FABP concentrations in nonalcoholic fatty liver disease. Possible marker for subclinical myocardial damage and subclinical atherosclerosis.

Authors:  O Başar; E Akbal; S Köklü; Y Tuna; E Koçak; N Başar; D Tok; H Erbiş; M Senes
Journal:  Herz       Date:  2013-01-18       Impact factor: 1.443

Review 10.  Circulating microRNAs as novel biomarkers for the early diagnosis of acute coronary syndrome.

Authors:  J C Deddens; J M Colijn; M I F J Oerlemans; G Pasterkamp; S A Chamuleau; P A Doevendans; J P G Sluijter
Journal:  J Cardiovasc Transl Res       Date:  2013-07-30       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.